Immune surveillance of tumorsJeremy B. Swann, Mark J. Smyth|Journal of Clinical Investigation|2007Cited by 1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialSherene Loi, Christos Sotiriou, Carsten Denkert et al.|Annals of Oncology|2014Cited by 1.3k
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsYulong Gao, Mark J. Smyth, Fernando Souza-Fonseca-Guimarães et al.|Nature Immunology|2017Cited by 639
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaHang Quach, H. Miles Prince, David Ritchie et al.|Leukemia|2009Cited by 586
Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramideMark J. Smyth, Dale I. Godfrey|Blood|2002Cited by 383